Davol, P A; Bizuneh, A; Frackelton Jr, A R (1999) Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo. Anticancer Res 19:1705-13 |
Davol, P A; Frackelton Jr, A R (1999) Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: characterizing and circumventing mechanisms of tumor resistance. Prostate 40:178-91 |
Davol, P A; Garza, S; Frackelton Jr, A R (1999) Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model. Cancer 86:1733-41 |